Joy Cavagnaro - Concepedia

Author

Joy Cavagnaro

Access to Wholistic and Productive Living Institute

Also Known As

Cavagnaro, Joy, J A Cavagnaro, J Cavagnaro, J. A. CAVAGNARO, J. A. Cavagnaro, J. Cavagnaro, J.A. Cavagnaro, JOY CAVAGNARO, Joy A Cavagnaro, Joy A. Cavagnaro

Publications

2.3K

Citations

H-Index

Concepts

All Affiliations

Access to Wholistic and Productive Living Institute Aging Community Coordinated Enterprises and Supportive Services (United States)National Institutes of Health Charles River Laboratories (United States)Kyoto University

About

Joy Cavagnaro is an author at Access to Wholistic and Productive Living Institute specializing in medicine, pharmacology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	12	394
2	Health Sciences	4	4	125
3	Allergy	4	4	155
4	Biochemistry	3	3	70
5	Biomedical Engineering	1	1	24

Joy Cavagnaro

Publications

540

Citations

H-Index

Page 1

	Year	Citations
Use of Tissue Cross-reactivity Studies in the Development of Antibody-based Biopharmaceuticals Michael W. Leach, Wendy Halpern, Carol W. Johnson, Toxicologic Pathology Tissue Cross-reactivityImmunocytochemical TechniqueImmunologyTissue Cross-reactivity StudiesPathology	2010	98
Harmonizing standards for producing clinical-grade therapies from pluripotent stem cells Peter W. Andrews, Joy Cavagnaro, Robert Deans, Nature Biotechnology Tissue EngineeringRegenerative MedicineInduced Pluripotent Stem CellPluripotent Stem CellsMedicine	2014	63
Norcocaine nitroxide. A potential hepatotoxic metabolite of cocaine. Elmer J. Rauckman, Gerald M. Rosen, Joy Cavagnaro Molecular Pharmacology	1982	58
Practical approaches to dose selection for first-in-human clinical trials with novel biopharmaceuticals Jay Tibbitts, Joy Cavagnaro, Christine Haller, Regulatory Toxicology and Pharmacology Practical ApproachesPharmacologyClinical TrialsNovel BiopharmaceuticalsPharmacotherapy	2010	53
Oligo Safety Working Group Exaggerated Pharmacology Subcommittee Consensus Document Doug Kornbrust, Joy Cavagnaro, Arthur A. Levin, Nucleic Acid Therapeutics	2013	45
Regulatory concerns in the development of topical recombinant ophthalmic and cutaneous wound healing biologics Kurt Stromberg, Mrunal S. Chapekar, Bette A. Goldman, Wound Repair and Regeneration	1994	32
Involvement of FAD-containing monooxygenase in cocaine-induced hepatotoxicity Michelle W. Kloss, Joy Cavagnaro, Gerald M. Rosen, Toxicology and Applied Pharmacology BiochemistryMedicineLiver PhysiologyFad-containing MonooxygenaseToxicology	1982	28
Clinical Expert Panel on Monitoring Potential Lung Toxicity of Inhaled Oligonucleotides: Consensus Points and Recommendations Eric W.F.W. Alton, Homer A. Boushey, Holger Garn, Nucleic Acid Therapeutics AsthmaClinical Expert PanelAllergyConsensus PointsAdvanced Lung Disease	2012	25
Report of the international conference on manufacturing and testing of pluripotent stem cells Stewart Abbot, F R Agbanyo, Jan‐Eric Ahlfors, Biologicals Regenerative MedicineInduced Pluripotent Stem CellDevelopmental BiologyPluripotent Stem CellsMedicine	2018	24
Interrelationships between water and cellular metabolism in <i>Artemia</i> cysts IV. Adenosine 5′‐triphosphate and cyst hydration James S. Clegg, Joy Cavagnaro Journal of Cellular Physiology Dried CystsCellular PhysiologyBioenergeticsBioanalysisCellular Metabolism	1976	21

Page 1